|
MELVILLE, NY, May 15, 2006
Allion Healthcare, Inc. (The Company) (NASDAQ: ALLI), a national provider of specialty pharmacy and disease management services focused on HIV/AIDS patients, announced today that it has received written confirmation from the NASDAQ Stock Market that the Company has satisfied the listing requirements set forth in Marketplace Rule 4350(d)(2) (the Rule), regarding Audit Committee requirements.
On May 12, 2006 Allions Board of Directors announced the appointment of Russell Fichera as an independent non-executive director and member of the Audit Committee. With this appointment, the Company now has three independent members on its Audit Committee, thereby fulfilling the Rule and bringing the matter to a close.
|